Douglas J Weschules

Summary

Country: USA

Publications

  1. doi request reprint A systematic review of opioid conversion ratios used with methadone for the treatment of pain
    Douglas J Weschules
    excelleRx, Inc, An Omnicare Company, Philadelphia, Pennsylvania 19102, USA
    Pain Med 9:595-612. 2008
  2. ncbi request reprint Are newer, more expensive pharmacotherapy options associated with superior symptom control compared to less costly agents used in a collaborative practice setting?
    Douglas J Weschules
    excellRx, Inc, Philadelphia, PA, USA
    Am J Hosp Palliat Care 23:135-49. 2006
  3. ncbi request reprint Toward evidence-based prescribing at end of life: a comparative analysis of sustained-release morphine, oxycodone, and transdermal fentanyl, with pain, constipation, and caregiver interaction outcomes in hospice patients
    Douglas J Weschules
    excelleRx, Inc, Philadelphia, PA 19102, USA
    Pain Med 7:320-9. 2006
  4. ncbi request reprint Toward evidence-based prescribing at end of life: a comparative review of temazepam and zolpidem for the treatment of insomnia
    Kevin T Bain
    excelleRx, Inc, Philadelphia, Pennsylvania, USA
    Am J Hosp Palliat Care 20:382-8. 2003
  5. ncbi request reprint Actual and potential drug interactions associated with methadone
    Douglas J Weschules
    excelleRx, Inc, An Omnicare Company, Philadelphia, Pennsylvania, USA
    Pain Med 9:315-44. 2008
  6. ncbi request reprint Methadone and the hospice patient: prescribing trends in the home-care setting
    Douglas J Weschules
    ExcelleRx Institute, Philadelphia, Pennsylvania 19106, USA
    Pain Med 4:269-76. 2003
  7. ncbi request reprint Development of guidelines for palliative care pharmacotherapy
    Douglas J Weschules
    excellRx, Inc, Philadelphia, PA, 19106, USA
    J Pain Palliat Care Pharmacother 19:25-38. 2005
  8. ncbi request reprint Medication inappropriateness for older adults receiving hospice care: a pilot survey
    Kevin T Bain
    Department of Quality Outcomes, excelleRx, Inc, Philadelphia, PA 19102, USA
    Consult Pharm 22:926-34. 2007
  9. ncbi request reprint Tolerability of the compound ABHR in hospice patients
    Douglas J Weschules
    excelleRx, Inc, Philadelphia, Pennsylvania 19102, USA
    J Palliat Med 8:1135-43. 2005
  10. doi request reprint Acetylcholinesterase inhibitor and N-methyl-D-aspartic acid receptor antagonist use among hospice enrollees with a primary diagnosis of dementia
    Douglas J Weschules
    GlaxoSmithKline, Philadelphia, Pennsylvania 19101, USA
    J Palliat Med 11:738-45. 2008

Detail Information

Publications10

  1. doi request reprint A systematic review of opioid conversion ratios used with methadone for the treatment of pain
    Douglas J Weschules
    excelleRx, Inc, An Omnicare Company, Philadelphia, Pennsylvania 19102, USA
    Pain Med 9:595-612. 2008
    ..Review and analyze the evidence base comprising methadone conversion methods and associated dosing ratios for the treatment of pain...
  2. ncbi request reprint Are newer, more expensive pharmacotherapy options associated with superior symptom control compared to less costly agents used in a collaborative practice setting?
    Douglas J Weschules
    excellRx, Inc, Philadelphia, PA, USA
    Am J Hosp Palliat Care 23:135-49. 2006
    ..0513); however, neither difference was statistically significant. Newer pharmacotherapy options for the management of pain, insomnia, and nausea were not found to be superior when compared to older agents prescribed under CP...
  3. ncbi request reprint Toward evidence-based prescribing at end of life: a comparative analysis of sustained-release morphine, oxycodone, and transdermal fentanyl, with pain, constipation, and caregiver interaction outcomes in hospice patients
    Douglas J Weschules
    excelleRx, Inc, Philadelphia, PA 19102, USA
    Pain Med 7:320-9. 2006
    ..The outcomes examined include: pain score, constipation severity, and ability of the patient to communicate with caregivers...
  4. ncbi request reprint Toward evidence-based prescribing at end of life: a comparative review of temazepam and zolpidem for the treatment of insomnia
    Kevin T Bain
    excelleRx, Inc, Philadelphia, Pennsylvania, USA
    Am J Hosp Palliat Care 20:382-8. 2003
    ..After review of the primary literature and the prescribing patterns in our setting, there is currently no evidence in our patient population to support that zolpidem is superior to benzodiazepines for the treatment of insomnia...
  5. ncbi request reprint Actual and potential drug interactions associated with methadone
    Douglas J Weschules
    excelleRx, Inc, An Omnicare Company, Philadelphia, Pennsylvania, USA
    Pain Med 9:315-44. 2008
    ..To identify and characterize methadone-related drug interactions, as well as factors accounting for the variability in manifesting these interactions clinically...
  6. ncbi request reprint Methadone and the hospice patient: prescribing trends in the home-care setting
    Douglas J Weschules
    ExcelleRx Institute, Philadelphia, Pennsylvania 19106, USA
    Pain Med 4:269-76. 2003
    ..To identify frequency and utilization patterns of methadone by hospice patients in the home-care setting...
  7. ncbi request reprint Development of guidelines for palliative care pharmacotherapy
    Douglas J Weschules
    excellRx, Inc, Philadelphia, PA, 19106, USA
    J Pain Palliat Care Pharmacother 19:25-38. 2005
    ..The process used by one national palliative care pharmacy company to create palliative care guidelines and algorithms is described along with some of the challenges in validating such tools...
  8. ncbi request reprint Medication inappropriateness for older adults receiving hospice care: a pilot survey
    Kevin T Bain
    Department of Quality Outcomes, excelleRx, Inc, Philadelphia, PA 19102, USA
    Consult Pharm 22:926-34. 2007
    ..To test the feasibility and reliability of a tool and methodology for evaluating expert clinicians' perceptions about the application of the Beers criteria in hospice...
  9. ncbi request reprint Tolerability of the compound ABHR in hospice patients
    Douglas J Weschules
    excelleRx, Inc, Philadelphia, Pennsylvania 19102, USA
    J Palliat Med 8:1135-43. 2005
    ....
  10. doi request reprint Acetylcholinesterase inhibitor and N-methyl-D-aspartic acid receptor antagonist use among hospice enrollees with a primary diagnosis of dementia
    Douglas J Weschules
    GlaxoSmithKline, Philadelphia, Pennsylvania 19101, USA
    J Palliat Med 11:738-45. 2008
    ....